| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
1.1055 -0.044 (-0.04%) |
07-22 11:18 |
|
Open: |
1.13 |
Pre close: |
1.15 |
Target:
|
2.09 
|
|
High: |
1.16 |
Low: |
1.07 |
Resistance:
|
1.79
2.24
|
|
Volume: |
102,086 |
Market Cap: |
23M |
Support:
|
1.05
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.24
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
1.55 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
1.17 |
Stochastic Oscillator |
%K(14,3):
|
6.34  |
|
MA(250): |
1.38 |
%D(3): |
6.66 |
|
Average Volume(K) |
3-Month: |
279988
|
52-Week |
High:
|
4.04 |
|
10-Days: |
35749 |
Low: |
0.23 |
|
RSI |
RSI(14):
|
40.32 |
Change(%): |
-52.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.571 |
Return on Equity (ttm) |
-171.7 |
Shares Out. (M) |
18.99 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-50.8 |
Shares Float (M) |
8.37 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.87 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-49.4 |
% Held by Institutions |
4.11 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.580 |
Shares Short (K) |
149 |
|
Book Value (p.s.) |
0.070 |
EBITDA (p.s.) |
-0.491 |
P/E |
-2.01 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
16.43 |
|
Profit Margin |
-77.67 |
Operating Cash Flow
(M) |
-8.32 |
P/S |
33597692.00 |
|
Operating Margin |
-86.63 |
Levered Free Cash Flow
(M) |
-4.79 |
P/CF |
-2.62 |
|
|
|
|
|
|
